PM Live RSS Feed :: Pharmaceutical Industry RSS http://www.pmlive.com PM Live RSS Feed :: Pharmaceutical Industry RSS en-gb Pharma 'struggling to prove value' as healthcare budgets tighten http://www.pmlive.com/pharma_news/pharma_struggles_prove_value_healthcare_budgets_tighten_367888 Tue, 07 Feb 2012 10:32:18 +0000 http://www.pmlive.com/pharma_news/pharma_struggles_prove_value_healthcare_budgets_tighten_367888 GSK suspends trials of novel antibiotic http://www.pmlive.com/pharma_news/gsk_suspends_trials_novel_antibiotic_367890 Tue, 07 Feb 2012 10:43:56 +0000 http://www.pmlive.com/pharma_news/gsk_suspends_trials_novel_antibiotic_367890 Rajesh Chopra joins board of e-Therapeutics http://www.pmlive.com/pharma_news/rajesh_chopra_joins_board_e-therapeutics_367871 Tue, 07 Feb 2012 09:25:01 +0000 http://www.pmlive.com/pharma_news/rajesh_chopra_joins_board_e-therapeutics_367871 Almirall files cannabis-based MS drug Sativex in additional EU markets http://www.pmlive.com/pharma_news/almirall_files_ms_drug_sativex_additional_eu_markets_367875 Tue, 07 Feb 2012 09:36:59 +0000 http://www.pmlive.com/pharma_news/almirall_files_ms_drug_sativex_additional_eu_markets_367875 Novartis’ Galvus gains monotherapy licence in Europe http://www.pmlive.com/pharma_news/novartis_galvus_monotherapy_licence_diabetes_europe_364974 Mon, 06 Feb 2012 17:17:16 +0000 http://www.pmlive.com/pharma_news/novartis_galvus_monotherapy_licence_diabetes_europe_364974 Merck & Co prepares to first-in-class insomnia drug for US approval http://www.pmlive.com/pharma_news/merck_co_insomnia_drug_suvorexant_us_filing_364975 Mon, 06 Feb 2012 17:28:49 +0000 http://www.pmlive.com/pharma_news/merck_co_insomnia_drug_suvorexant_us_filing_364975 Boehringer to research cause of diabetes with German university http://www.pmlive.com/pharma_news/boehringer_research_cause_diabetes_dresden_university_361534 Mon, 06 Feb 2012 10:23:07 +0000 http://www.pmlive.com/pharma_news/boehringer_research_cause_diabetes_dresden_university_361534 Olanzapine drives Dr Reddy's business in third quarter http://www.pmlive.com/pharma_news/olanzapine_dr_reddys_third_quarter_results_361536 Mon, 06 Feb 2012 10:30:43 +0000 http://www.pmlive.com/pharma_news/olanzapine_dr_reddys_third_quarter_results_361536 Sucampo-Takeda to file for US approval of Amitiza as OBD treatment http://www.pmlive.com/pharma_news/sucampo-takeda_file_us_approval_lubiprostone_obd_treatment_361549 Mon, 06 Feb 2012 10:39:38 +0000 http://www.pmlive.com/pharma_news/sucampo-takeda_file_us_approval_lubiprostone_obd_treatment_361549 Merck KGaA signs $750m deal for late-stage cancer drug http://www.pmlive.com/pharma_news/merck_kgaa_cancer_deal_threshold_hypoxia_361307 - 06/02/2012]]> Fri, 03 Feb 2012 15:19:51 +0000 http://www.pmlive.com/pharma_news/merck_kgaa_cancer_deal_threshold_hypoxia_361307